Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Don A Gabriel

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cancer Investigation|February 15, 2011
Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myelomaAnne W Beaven, Dominic T Moore, Andrew Sharf, et al.
Hepatology (Baltimore, Md.)|February 8, 2013
Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failureR Todd Stravitz, Regina Bowling, Robert L Bradford, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2006
Pharmacokinetics of ganciclovir after oral valganciclovir versus intravenous ganciclovir in allogeneic stem cell transplant patients with graft-versus-host disease of the gastrointestinal tractDrew J Winston, Lindsey R Baden, Don A Gabriel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2005
Cytoprotection by amifostine during autologous stem cell transplantation for advanced refractory hematologic malignanciesDon A Gabriel, Thomas C Shea, Jonathan S Serody, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 27, 2006
Unfractionated heparin reduces the anti-platelet effects of abciximab but not eptifibatide during PCIEfthymios N Deliargyris, Bharathi Upadhya, Laura G Melton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 11, 2009
Intravesicular cidofovir for the management of BK virus-associated cystitisKamakshi V Rao, Larry W Buie, Thomas Shea, et al.
Leukemia & Lymphoma|April 10, 2009
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survivalThomas C Shea, Anne W Beaven, Dominic T Moore, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 19, 2003
An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignanciesThomas C Shea, Rebecca Bruner, Joseph M Wiley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 8, 2014
Effectiveness of an algorithm-based approach to the utilization of plerixafor in patients undergoing chemotherapy-based stem cell mobilizationEric Chow, Kamakshi V Rao, William A Wood, et al.
Blood|August 17, 2012
B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathwaysJessica L Allen, Matthew S Fore, Jenna Wooten, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer Investigation|February 15, 2011
Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myelomaAnne W Beaven, Dominic T Moore, Andrew Sharf, et al.
Hepatology (Baltimore, Md.)|February 8, 2013
Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failureR Todd Stravitz, Regina Bowling, Robert L Bradford, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2006
Pharmacokinetics of ganciclovir after oral valganciclovir versus intravenous ganciclovir in allogeneic stem cell transplant patients with graft-versus-host disease of the gastrointestinal tractDrew J Winston, Lindsey R Baden, Don A Gabriel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2005
Cytoprotection by amifostine during autologous stem cell transplantation for advanced refractory hematologic malignanciesDon A Gabriel, Thomas C Shea, Jonathan S Serody, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 27, 2006
Unfractionated heparin reduces the anti-platelet effects of abciximab but not eptifibatide during PCIEfthymios N Deliargyris, Bharathi Upadhya, Laura G Melton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 11, 2009
Intravesicular cidofovir for the management of BK virus-associated cystitisKamakshi V Rao, Larry W Buie, Thomas Shea, et al.
Leukemia & Lymphoma|April 10, 2009
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survivalThomas C Shea, Anne W Beaven, Dominic T Moore, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 19, 2003
An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignanciesThomas C Shea, Rebecca Bruner, Joseph M Wiley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 8, 2014
Effectiveness of an algorithm-based approach to the utilization of plerixafor in patients undergoing chemotherapy-based stem cell mobilizationEric Chow, Kamakshi V Rao, William A Wood, et al.
Blood|August 17, 2012
B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathwaysJessica L Allen, Matthew S Fore, Jenna Wooten, et al.
Pageof 3